Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — November 2022

Genmab — November 2022

Planlagt Fastgjort Låst Flyttet Genmab
1.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    bikube
    wrote on sidst redigeret af
    #950

    Nu er $ kursen faldet 10% fra toppen, det betyder jo en del for Genmabs indtægt. Det er dog lidt specielt, at olien falder samtidig.

    1 Reply Last reply
    0
    • G Offline
      G Offline
      GeorgeBest
      wrote on sidst redigeret af
      #951

      Olie, USD, inflation og renter kommer ned de næste 12 mdr !

      1 Reply Last reply
      0
      • G Offline
        G Offline
        GeorgeBest
        wrote on sidst redigeret af
        #952

        Ny ATH, nice 🙂

        1 Reply Last reply
        0
        • concilladoC Offline
          concilladoC Offline
          concillado
          wrote on sidst redigeret af
          #953

          yeehaw! 🙂

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #954

            Hhhmmm hvad er der mon gang i?

            1 Reply Last reply
            0
            • G Offline
              G Offline
              GeorgeBest
              wrote on sidst redigeret af
              #955

              GEN1042 nyheder på torsdag???

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #956

                Link Preview Image
                ESMO I-O 2022 - Online Programme - ESMO Immuno-Oncology Congress 2022

                favicon

                (cslide.ctimeetingtech.com)

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #957

                  poster 175 - ja lad os håbe det er lovende data derfra

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #958

                    After FDA Rejection, Spectrum Shelves Development On Poziotinib https://finance.yahoo.com/news/fda-rejection-spectrum-shelves-development-145947732.html ; potential amivantamab competitor, even though ami was deemed superior already https://www.clinicaltrialsarena.com/comment/janssens-amivantamab-has-competitive-edge-over-spectrums-and-takedas-exon-20-mutation-directed-tkis-in-nsclc/

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #959

                      Genmab udvisker fald og går på rekordjagt https://www.proinvestor.com/investornyt/909356/genmab-udvisker-fald-og-gar-pa-rekordjagt-ny

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #960

                        GEN1053 TRIPLING the number of treatment centers !! ( form 1 to 3 😄 ) #newspaperheadlines https://clinicaltrials.gov/ct2/history/NCT05435339?A=4&B=5&C=merged#StudyPageTop

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #961

                          November 28
                          Genmab A/S (NASDAQ: GMAB) New Catalyst Idea of Morgan Stanley.Analyst Matt Harrison comments "What is thecatalyst? This arbitration flows from the result of the first arbitration that ruled in favor of J&J ... -i can't read the rest...

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            gentogen
                            wrote on sidst redigeret af
                            #962

                            Once more well found! Interesting....

                            1 Reply Last reply
                            0
                            • T Offline
                              T Offline
                              Tommy_P.
                              wrote on sidst redigeret af
                              #963

                              Mange tak EL.

                              1 Reply Last reply
                              0
                              • StockBullS Offline
                                StockBullS Offline
                                StockBull
                                wrote on sidst redigeret af
                                #964

                                Morning. Betalings site https://www.streetinsider.com/Analyst+Comments/Genmab+AS+(GMAB)+New+Catalyst+Idea+of+Morgan+Stanley/20902723.html Morgan Stanley har lavt target og historien melder ikke om opjusteret target for så ville det have været på mange andre kendte sites

                                1 Reply Last reply
                                0
                                • Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktør
                                  wrote on sidst redigeret af
                                  #965

                                  Godmorgen 🙂

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Stroka
                                    wrote on sidst redigeret af
                                    #966

                                    God morgen 🙂

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      GeorgeBest
                                      wrote on sidst redigeret af
                                      #967

                                      Vedr. 23:29 Morgan Stanley der jo er negative på Genmab forsøger, som jeg læser de 2 linier, at fortælle at da voldgiften er baseret på 1. ruling i JNJ favør, så har Genmab ringe chancer…PS jeg er ikke jurist så jeg aner ikke hvilken vej det går. Jeg har også valgt ikke at sætte store forhåbninger i voldgift nr. 2, for ikke at blive skuffet igen. Der er for mig at se nok andre katalysorer for en positiv Genmab udvikling

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        ProinvestorNEWS
                                        wrote on sidst redigeret af
                                        #968

                                        Tirsdagens aviser med Jyske Bank, SAS og Novo Nordisk https://www.proinvestor.com/investornyt/909592/tirsdagens-aviser-med-jyske-bank-sas-og-novo-nordisk

                                        1 Reply Last reply
                                        0
                                        • StockBullS Offline
                                          StockBullS Offline
                                          StockBull
                                          wrote on sidst redigeret af
                                          #969

                                          Link Preview Image
                                          Watching Genmab A/S; Hearing Oxford Momentum Newsletter Buys Stock - Genmab (NASDAQ:GMAB)

                                          favicon

                                          Benzinga (www.benzinga.com)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper